SI21637A - Farmacevtska oblika z nadzorovanim sproščanjem - Google Patents
Farmacevtska oblika z nadzorovanim sproščanjem Download PDFInfo
- Publication number
- SI21637A SI21637A SI200300317A SI200300317A SI21637A SI 21637 A SI21637 A SI 21637A SI 200300317 A SI200300317 A SI 200300317A SI 200300317 A SI200300317 A SI 200300317A SI 21637 A SI21637 A SI 21637A
- Authority
- SI
- Slovenia
- Prior art keywords
- coating
- pharmaceutical
- polymer
- pharmaceutical form
- form according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200300317A SI21637A (sl) | 2003-12-23 | 2003-12-23 | Farmacevtska oblika z nadzorovanim sproščanjem |
ARP040104829A AR048138A1 (es) | 2003-12-23 | 2004-12-21 | Formulacion farmaceutica de liberacion controlada |
EP04809252A EP1699439A2 (fr) | 2003-12-23 | 2004-12-22 | Formulation pharmaceutique a liberation controlee |
US10/583,440 US20070141149A1 (en) | 2003-12-23 | 2004-12-22 | Controlled-release pharmaceutical formulation |
CA2547586A CA2547586C (fr) | 2003-12-23 | 2004-12-22 | Formulation pharmaceutique a liberation controlee |
JP2006546934A JP2007516282A (ja) | 2003-12-23 | 2004-12-22 | 放出制御医薬製剤 |
BRPI0418122-0A BRPI0418122A (pt) | 2003-12-23 | 2004-12-22 | formulação farmacêutica de liberação controlada |
AU2004305422A AU2004305422B2 (en) | 2003-12-23 | 2004-12-22 | Controlled-release pharmaceutical formulation |
RU2006126786/15A RU2447884C2 (ru) | 2003-12-23 | 2004-12-22 | Фармацевтический состав с контролируемым высвобождением действующего вещества |
PCT/SI2004/000044 WO2005060939A2 (fr) | 2003-12-23 | 2004-12-22 | Formulation pharmaceutique a liberation controlee |
CNA2004800388929A CN1897923A (zh) | 2003-12-23 | 2004-12-22 | 控释药物制剂 |
ZA200603656A ZA200603656B (en) | 2003-12-23 | 2006-05-09 | Controlled-release pharmaceutical formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200300317A SI21637A (sl) | 2003-12-23 | 2003-12-23 | Farmacevtska oblika z nadzorovanim sproščanjem |
Publications (1)
Publication Number | Publication Date |
---|---|
SI21637A true SI21637A (sl) | 2005-06-30 |
Family
ID=34709497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200300317A SI21637A (sl) | 2003-12-23 | 2003-12-23 | Farmacevtska oblika z nadzorovanim sproščanjem |
Country Status (12)
Country | Link |
---|---|
US (1) | US20070141149A1 (fr) |
EP (1) | EP1699439A2 (fr) |
JP (1) | JP2007516282A (fr) |
CN (1) | CN1897923A (fr) |
AR (1) | AR048138A1 (fr) |
AU (1) | AU2004305422B2 (fr) |
BR (1) | BRPI0418122A (fr) |
CA (1) | CA2547586C (fr) |
RU (1) | RU2447884C2 (fr) |
SI (1) | SI21637A (fr) |
WO (1) | WO2005060939A2 (fr) |
ZA (1) | ZA200603656B (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006232696A (ja) * | 2005-02-23 | 2006-09-07 | Taisho Pharm Ind Ltd | 徐放性製剤 |
WO2009063916A1 (fr) | 2007-11-16 | 2009-05-22 | Asahi Kasei Chemicals Corporation | Solution aqueuse de pelliculage, granulés de pelliculage et comprimé renfermant les granulés de pelliculage |
EA019572B1 (ru) * | 2008-11-18 | 2014-04-30 | Юсб Фарма, С.А. | Фармацевтические пероральные композиции с пролонгированным высвобождением, включающие производные 2-оксо-1-пирролидина |
AU2022374786A1 (en) | 2021-10-25 | 2024-06-13 | Farmalíder, S.A. | Tadalafil oral suspension |
CN115300506A (zh) * | 2022-08-11 | 2022-11-08 | 南京红地生物科技有限公司 | 含有坦索罗辛和米拉贝隆的复方制剂及其制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4772475A (en) * | 1985-03-08 | 1988-09-20 | Yamanouchi Pharmaceutical Co., Ltd. | Controlled-release multiple units pharmaceutical formulation |
PH27186A (en) * | 1989-09-07 | 1993-04-16 | Ciba Geigy Ag | Double-coated granules of disodium pamidronate |
US5041430A (en) * | 1989-09-18 | 1991-08-20 | Du Pont Mereck Pharmaceutical Company | Oral anticoagulant/platelet inhibitor low dose formulation |
ZA919510B (en) * | 1990-12-05 | 1992-10-28 | Smithkline Beecham Corp | Pharmaceutical compositions |
EP0520119A1 (fr) * | 1991-06-17 | 1992-12-30 | Spirig Ag Pharmazeutische Präparate | Composition à base de diclofenac pour l'administration orale |
GB9117361D0 (en) * | 1991-08-12 | 1991-09-25 | Euro Celtique Sa | Oral dosage form |
GB2343634A (en) * | 1997-08-01 | 2000-05-17 | Acushnet Co | Golf ball and method of making same |
EA002806B1 (ru) * | 1997-09-11 | 2002-10-31 | Нюкомед Данмарк А/С | Многоединичные композиции с модифицированным высвобождением нестероидных противовоспалительных лекарственных веществ (nsaid) |
US6602522B1 (en) * | 1997-11-14 | 2003-08-05 | Andrx Pharmaceuticals L.L.C. | Pharmaceutical formulation for acid-labile compounds |
JP2003523372A (ja) * | 2000-02-24 | 2003-08-05 | アドバンシス ファーマシューティカル コーポレイション | 抗生物質及び抗真菌剤組成物 |
US6610328B2 (en) * | 2000-02-24 | 2003-08-26 | Advancis Pharmaceutical Corp. | Amoxicillin-clarithromycin antibiotic composition |
RU2245136C2 (ru) * | 2001-07-27 | 2005-01-27 | Яманоути Фармасьютикал Ко., ЛТД | Композиция, включающая тонкодисперсные частицы с замедленным высвобождением для быстроразлагающихся в щечной полости таблеток, и способ ее получения |
US20030224050A1 (en) * | 2002-01-04 | 2003-12-04 | Charles Chiao | Drug delivery system for sustained delivery of glipizide |
US7018658B2 (en) * | 2002-11-14 | 2006-03-28 | Synthon Bv | Pharmaceutical pellets comprising tamsulosin |
-
2003
- 2003-12-23 SI SI200300317A patent/SI21637A/sl not_active IP Right Cessation
-
2004
- 2004-12-21 AR ARP040104829A patent/AR048138A1/es not_active Application Discontinuation
- 2004-12-22 EP EP04809252A patent/EP1699439A2/fr not_active Ceased
- 2004-12-22 CA CA2547586A patent/CA2547586C/fr not_active Expired - Fee Related
- 2004-12-22 BR BRPI0418122-0A patent/BRPI0418122A/pt not_active IP Right Cessation
- 2004-12-22 AU AU2004305422A patent/AU2004305422B2/en not_active Ceased
- 2004-12-22 CN CNA2004800388929A patent/CN1897923A/zh active Pending
- 2004-12-22 WO PCT/SI2004/000044 patent/WO2005060939A2/fr active Application Filing
- 2004-12-22 JP JP2006546934A patent/JP2007516282A/ja active Pending
- 2004-12-22 RU RU2006126786/15A patent/RU2447884C2/ru not_active IP Right Cessation
- 2004-12-22 US US10/583,440 patent/US20070141149A1/en not_active Abandoned
-
2006
- 2006-05-09 ZA ZA200603656A patent/ZA200603656B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2004305422B2 (en) | 2010-12-23 |
EP1699439A2 (fr) | 2006-09-13 |
BRPI0418122A (pt) | 2007-04-17 |
RU2447884C2 (ru) | 2012-04-20 |
RU2006126786A (ru) | 2008-01-27 |
CA2547586C (fr) | 2012-12-04 |
CN1897923A (zh) | 2007-01-17 |
ZA200603656B (en) | 2007-09-26 |
AR048138A1 (es) | 2006-04-05 |
AU2004305422A1 (en) | 2005-07-07 |
WO2005060939A2 (fr) | 2005-07-07 |
JP2007516282A (ja) | 2007-06-21 |
WO2005060939A3 (fr) | 2005-12-29 |
CA2547586A1 (fr) | 2005-07-07 |
US20070141149A1 (en) | 2007-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5529790A (en) | Delayed, sustained-release diltiazem pharmaceutical preparation | |
KR100735509B1 (ko) | 지연 작용을 갖는 경구 약제학적 투여 형태 | |
AU760006B2 (en) | Method for making granules with masked taste and instant release of the active particle | |
US8968777B2 (en) | Tranexamic acid formulations with reduced adverse effects | |
CA2415840C (fr) | Pastilles pharmaceutiques comprenant de la tamsulosine et processus de fabrication de ces pastilles | |
EP0194838A2 (fr) | Formulation pharmaceutique à libération contrôlée | |
CZ2002671A3 (cs) | Léková forma se zpoľděným účinkem obsahující tramadolsacharinát | |
JP2001526213A (ja) | 経口医薬パルス放出剤形 | |
KR20080007252A (ko) | 양성 전립선 과다형성증용 치료 조합물 | |
BR112013003581B1 (pt) | Composição farmacêutica ou nutracêutica gastro resistente, que compreende um ou mais sais do ácido algínico, e seu processo de produção | |
US20150140089A1 (en) | Novel formulations of nitrofurans including nifurtimox with enhanced activity with lower toxicity | |
ZA200603656B (en) | Controlled-release pharmaceutical formulation | |
EP1283701A1 (fr) | Une composition de pellicule pour faciliter la liberation regulee | |
WO2004024128A2 (fr) | Composition pharmaceutique a liberation modifiee | |
WO2009065130A2 (fr) | Formulations à libération modifiée de diltiazème | |
US20030157174A1 (en) | Enteric granular preparations of hardly water soluble drugs characterized by containing water-repellent component | |
CZ118899A3 (cs) | Kompozice s pozvolným uvolňováním léčiva, způsob přípravy této kompozice, způsob zlepšení profilu uvolňování léčiva a použití této kompozice | |
JP4840793B2 (ja) | 撥水性成分を配合することを特徴とする難水溶性薬物の腸溶顆粒製剤 | |
MXPA06007316A (en) | Controlled-release pharmaceutical formulation | |
RU2292877C2 (ru) | Лекарственная ретард-форма, содержащая сахаринат трамадола | |
OA20182A (en) | A process for the preparation of a modified release multiple unit oral dosage form of doxylamine succinate and pyridoxine hydrochloride. | |
Rhee et al. | Controlled-release pelletized dosage forms using the extrusion-spheronization process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OO00 | Grant of patent |
Effective date: 20040316 |
|
KO00 | Lapse of patent |
Effective date: 20140205 |